More than 50 exhibitors will take part at the Life Sciences Baltics forum this year. Companies from Lithuania, Latvia, Estonia, Germany, Japan, UK, USA, Switzerland, France, Belgium and Finland will be showcasing its innovative technologies, products and services. Let’s have a quick look at selected few companies that organizers already know being of special interest for forum visitors.
- SatiMed (Lithuania). A company delivering the highest quality non-psychoactive phytocannabinoid nutritional and cosmetic products from EU-certified organic industrial hemp plants. They use innovative scientific production methods to transfer precious natural herbal compounds into the final product. Their ultimate goal is to provide the scientifically proven natural alternative to synthetic drugs that could challenge oncologic, inflammatory, neurodegenerative and other disorders.
- Japan Bioindustry Association. A non-profit organization established in 1987 that is now considered to be one of the leading global bioscience associations and the gateway to both Japanese and broader Asian markets. The organization is planning for sound development in bioscience-related industries and is dedicated to solving problems on a global scale through advances in bioscience.
- Baltic Ortho Implants (Lithuania). A trademark owned by Baltic Orthoservice, a company producing custom-made assistive orthopaedic devices. Ortho Baltic Implants produces a group of products that are implanted into human organism as well as related products, such as surgery instruments. The company produces patient-speciﬁc joints, cranial and spinal implants, bone plating systems, dental & jaw restoration implants and patient-speciﬁc surgical guides.
- Biomapas (Lithuania). A clinical trials, pharmacovigilance and regulatory affairs company with experience in therapeutic fields including psychiatry, cardiovascular, oncology, neurology, rheumatology, and pulmonology. It cooperates deeply with Lithuanian universities and medical institutions. Biomapas has the capability of conducting Phase I-IV clinical trials including bioequivalence (PK/PD) studies for the pharmaceutical and biotechnology industries.
- Charles River Biologics group (US). It offers a variety of services such as contamination and impurity testing, bioassays, viral clearance studies and stability and lot release programs, and they support clients throughout the biologic development cycle, from the establishment and characterization of cell banks through preclinical and clinical studies to marketed products.
- Philips BioCell (Denmark). It develops, produces and sells imaging analysis products to end users as well as supplying imaging and imaging analysis technology as an OEM and has partnerships with leading companies in different biotech analysis projects. It is a part of Philips Healthcare Incubator within Philips Innovation, Group & Services. Recently the company has released oCelloScope System™, an analytical instrument that is, amongst other applications, used within microbiological studies on a research application basis.
- Akron BioMedical Corridor (US). It is a synergistic collection of companies and organizations that are leaders in the fields of biomedicine and biomaterials. Through collaboration with the City of Akron, the Akron BioMedical Corridor attracts companies, both domestic and international, to bring their expertise and technology to the area, while assisting them in expanding their presence in the North American market.
- And 40+ more - from the Baltics and all around the world!
Life Sciences Baltics 2016 is the only international forum in the Baltics for world-class biotechnology, pharmaceutical and medical devices experts from all around the world consisting of high level conference, international business exhibition, start-up session, b2b partnering event and evening networking receptions.